MJ MedTech

MJ MedTech was a plant-based medicine and nutraceutical company focused on cannabinoid- and psilocybin-related products and research. The business developed and commercialized CBD and mushroom-based consumer health products under brands including Dr. AnnaRx, Medspresso, and Liviana, and it also described preclinical work in psilocybin extracts. The company was acquired in December 2018 by Wuhan General Group, later operating under the M2Bio Sciences name. Available public information indicates MJ MedTech functioned primarily as a branded consumer health and alternative medicine subsidiary rather than a traditional clinical-stage drug developer. It appears no longer to operate as an independent active company.